Wider Todd Insider Trading Activity

Average Profitability
76.01%
Insider Buys Quantity
3
Insider Buys Sum
$365,850.24
Insider Sells Quantity
8
Insider Sells Sum
$1.54M

Insider Activity of Wider Todd

According to the SEC Form 4 filings, Wider Todd, being in a position of

  1. director at ASP Isotopes Inc.,
    оver the last 12 months, has bought 0 shares, and sold 100000 shares for $618,500,
    over all time since 2023-10-26, has bought 94844 shares for $91,050, and sold 174108 shares for $1.27M.

Biography of Wider Todd

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$618,5002100

Comparison of Insiders on Amount of Buys and Sells

2026-06-30SaleASP Isotopes Inc.
ASPI
director
50,000
0.0592%
$6.12$306,000-37.86%
2026-06-29SaleASP Isotopes Inc.
ASPI
director
50,000
0.0605%
$6.25$312,500-37.78%
2025-09-15SaleASP Isotopes Inc.
ASPI
director
74,108
0.0762%
$8.76$648,823-38.12%
2023-10-26PurchaseASP Isotopes Inc.
ASPI
director
94,844
0.2319%
$0.96$91,050+178.1%
2021-10-07SaleAbeona Therapeutics Inc.
ABEO
director
25,000
0.0243%
$0.97$24,150-74.74%
2021-02-19SaleAbeona Therapeutics Inc.
ABEO
director
251,625
0.2647%
$2.39$601,057-47.72%
2021-02-18SaleAbeona Therapeutics Inc.
ABEO
director
1,345
0.0014%
$2.43$3,273-48.78%
2021-02-17SaleAbeona Therapeutics Inc.
ABEO
director
320,000
0.3025%
$2.34$749,792-52.09%
2021-01-04SaleAbeona Therapeutics Inc.
ABEO
director
33,876
0.0327%
$1.54$52,064-18.34%
2020-12-02SaleAbeona Therapeutics Inc.
ABEO
director
33,876
0.0349%
$1.49$50,546-1.28%
2020-11-23SaleAbeona Therapeutics Inc.
ABEO
director
17,969
0.0187%
$1.33$23,981+11.59%
2020-11-02SaleAbeona Therapeutics Inc.
ABEO
director
33,876
0.0367%
$1.04$35,106+49.51%
2016-09-20PurchaseAbeona Therapeutics Inc.
ABEO
director
10,000
0.0285%
$5.48$54,800+2.08%
2015-07-31PurchaseAbeona Therapeutics Inc.
ABEO
director
40,000
0.1073%
$5.50$220,000-54.26%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.